CANDELARIA HERNÁNDEZ, M.; LÓPEZ KARPOVITCH, X.; JAVIER MIJANGOS, F.; MONTAÑO, E.; LEMUS CARMONA, A.; GUZMÁN VÁZQUEZ, S.; SOTO MOLINA, H. Cost-Effectiveness of Azacitidine Compared with Low-Doses of Chemotherapy (LDC) in Myelodysplastic Syndrome (MDS). Global and Regional Health Technology Assessment, [S. l.], v. 4, n. 1, p. 114–121, 2017. DOI: 10.33393/grhta.2017.385. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/385. Acesso em: 22 nov. 2024.